Full Text View
Tabular View
No Study Results Posted
Related Studies
Glutathione in Diabetic Nephropathy (CGDN)
This study is currently recruiting participants.
Verified February 2013 by Department of Veterans Affairs
Study NCT01265563   Information provided by Department of Veterans Affairs

First Received on December 10, 2010.   Last Updated on February 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Proteinuria
Oxidative Stress
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Additional drug interventions recognized in this trial
Acetylcysteine
N-monoacetylcystine
Silybin
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Department of Veterans Affairs
National Center for Complementary and Alternative Medicine (NCCAM)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services